CausalSentinel

Protein Dossier — IL7R (Interleukin-7 receptor subunit alpha)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Inflammatory bowel disease 0.104 0.0247 2.48e-05 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypothyroidism or myxoedema 0.0948 0.0233 4.80e-05 Wald ratio 1 cis NA
Non-cancer illness code self-reported: asthma 0.0574 0.0153 1.69e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hayfever or allergic rhinitis 0.0784 0.0219 3.49e-04 Wald ratio 1 cis NA
Ulcerative colitis 0.102 0.0309 9.04e-04 Wald ratio 1 cis NA
Crohn’s disease 0.0964 0.0298 0.00123 Wald ratio 1 cis NA
Heel bone mineral density (BMD) T-score automated -0.0223 0.00746 0.00279 Wald ratio 1 cis NA
Height -0.0198 0.00706 0.00511 Wald ratio 1 cis NA
ER-negative Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) 0.0699 0.0268 0.00918 Wald ratio 1 cis NA
Juvenile idiopathic arthritis 0.323 0.127 0.011 Wald ratio 1 cis NA
Lung cancer -0.0971 0.041 0.018 Wald ratio 1 cis NA
Happiness 0.0168 0.00714 0.0182 Wald ratio 1 cis NA
…and 109 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-5089_11_3 IL-7 Ra Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

258 association rows across 144 traits (242 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating IL7R levels 1e-4083 rs11742270 4 GCST90860451 no MR -> candidate analysis
ICAM2/IL7R protein level ratio 3e-3651 rs6897932 1 GCST90315117 no MR -> candidate analysis
IL7R protein levels 8e-206 rs182158522 12 GCST90469605 no MR -> candidate analysis
Lymphocyte count 3e-144 rs11567699 7 GCST90002320 no MR -> candidate analysis
Hematological traits (multi-trait analysis) 1e-118 rs11567701 2 GCST90838669 no MR -> candidate analysis
Atopic dermatitis 3e-99 rs10214273 6 GCST90244787 no MR -> candidate analysis
Lymphocyte count (UKB data field 30120) 3e-86 rs1053496 1 GCST90468082 no MR -> candidate analysis
Eosinophil count 2e-66 rs1961220 8 GCST90002302 no MR -> candidate analysis
Lymphocyte percentage of white cells 1e-63 rs11567701 2 GCST90002389 no MR -> candidate analysis
Lymphocyte percentage (UKB data field 30180) 4e-61 rs11567701 1 GCST90468083 no MR -> candidate analysis
Eczema 2e-59 rs6881706 3 GCST007075 MR: beta=0.0584, p=0.146 (cis)
Eosinophill percentage (UKB data field 30210) 6e-53 rs4594881 1 GCST90468069 no MR -> candidate analysis
…and 132 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 872 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
immunodeficiency 104 0.889 established (curated) no MR -> candidate analysis
asthma 0.957 common-variant locus MR: beta=0.0574, p=1.69e-04 (cis)
multiple sclerosis 0.804 common-variant locus no MR -> candidate analysis
T-B+ severe combined immunodeficiency due to JAK3 deficiency 0.959 established (curated) no MR -> candidate analysis
hypothyroidism 0.935 common-variant locus MR: beta=0.0948, p=4.80e-05 (cis)
Omenn syndrome 0.608 established (curated) no MR -> candidate analysis
allergic rhinitis 0.904 common-variant locus MR: beta=0.0784, p=3.49e-04 (cis)
atopic eczema 0.903 common-variant locus no MR -> candidate analysis
Eczematoid dermatitis 0.897 common-variant locus no MR -> candidate analysis
primary biliary cholangitis 0.894 common-variant locus no MR -> candidate analysis
allergic disease 0.875 common-variant locus no MR -> candidate analysis
dermatitis 0.866 common-variant locus no MR -> candidate analysis
severe combined immunodeficiency 0.858 established (curated) no MR -> candidate analysis
skin disorder 0.846 common-variant locus no MR -> candidate analysis
respiratory system disorder 0.813 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 12 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=4e-11, LOEUF=1.06 — LoF-tolerant
GWAS Catalog 124 unique SNPs / 323 rows
ClinVar 635 records; 5 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance